Target intelligence / Profile preview

Gamma-crystallin S (CRYGS)

Target
CRYGS
Molecular classification
Structural protein, Crystallin family, Beta/gamma-crystallin superfamily, Other
01

Overview

Gamma-crystallin S is a monomeric structural protein and a member of the beta/gamma-crystallin family, primarily expressed in the vertebrate eye lens, where it plays a key role in maintaining lens transparency and refractive properties. CRYGS is highly stable and resistant to aggregation under normal conditions, but mutations—such as the G18V mutation—can disrupt its structure, leading to protein aggregation and cataract formation. This protein, like other crystallins, does not have known enzymatic or pharmacological "target" activity (e.g., it is not a receptor, enzyme, or transporter), but is critically important as a structural lens protein and is implicated in hereditary and age-related cataracts due to its accumulation and post-translational modifications over time.

Other names
Gamma-crystallin SCRYGSCRYG8Beta-crystallin SGamma-S-crystallincrystallin, gamma 8CTRCT20gamma-crystallin Sbeta-crystallin S
02

Biological functions

Maintenance of lens transparencyStructural support in the eye lensPrevention of protein aggregation in the lensOther
03

Disease associations

Cataract (congenital, age-related)Other
04

Safety considerations

Cataract-causing mutations impair structural integrity and cause light scattering in the lens

Beyond the preview

Go deeper on Gamma-crystallin S (CRYGS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gamma-crystallin S (CRYGS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call